Raffles Medical Group Ltd

SGX:BSL Rapporto sulle azioni

Cap. di mercato: S$1.6b

Raffles Medical Group Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Choon Yong Loo

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO35.6yrs
Proprietà del CEO13.5%
Durata media del management5.7yrs
Durata media del Consiglio di amministrazione4.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

May 09
Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Apr 25
Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10
Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Nov 16
Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Nov 03
Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

Aug 23
Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Jul 24
The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

Jun 13
Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

May 30
A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

May 12
Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

May 01
Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Mar 13
Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Feb 14
Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Dec 04
Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Nov 21
Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Oct 09
Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Sep 26
Is Raffles Medical Group (SGX:BSL) A Risky Investment?

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Sep 01
The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Aug 20
With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Jun 01
Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

May 02
Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Apr 18
We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Feb 21
Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Oct 14
Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Oct 02
Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Sep 21
At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Aug 12
Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

Jul 01
Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

May 25
At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

AMMINISTRATORE DELEGATO

Choon Yong Loo (75 yo)

35.6yrs

Mandato

Dr. Choon Yong Loo co-founded Group Ltd in 1976. He served as the Non-Independent Executive Chairman of Raffles Medical Group Ltd from 1997 until January 1, 2022, and has been its Executive Chairman and Ex...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Soo Nan Tan
Executive & Non-Independent Directorno dataNessun dato0.25%
SGD 3.9m
Qinghui Lu
Executive & Non-Independent Director4.5yrsNessun dato0.0032%
SGD 50.0k
Choon Yong Loo
Executive Chairman & CEOno dataNessun dato13.52%
SGD 209.8m
Kimmy Goh
Company Secretary & Group Financial Controller19.9yrsNessun datoNessun dato
Kah Ling Teo
Chief Information Officer6.9yrsNessun datoNessun dato
Joanna Lee
Senior Manager of Communicationsno dataNessun datoNessun dato
Kenneth Wu
Chief Operating Officer of Singapore Healthcareno dataNessun datoNessun dato
Vincent Chia
Managing Director of Raffles China Healthcare2.9yrsNessun datoNessun dato

5.7yrs

Durata media

75yo

Età media

Gestione esperta: Il team dirigenziale di BSL è esperto e expertise (durata media dell'incarico 5.7 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Soo Nan Tan
Executive & Non-Independent Director24.4yrsNessun dato0.25%
SGD 3.9m
Qinghui Lu
Executive & Non-Independent Director6.8yrsNessun dato0.0032%
SGD 50.0k
Choon Yong Loo
Executive Chairman & CEO35.6yrsNessun dato13.52%
SGD 209.8m
Tse Ghow Lim
Non-Executive & Non-Independent Director10.2yrsNessun dato0.028%
SGD 439.2k
Yoong Keong Lew
Lead Independent Director4.2yrsNessun dato0.011%
SGD 166.9k
Cheong Boon Png
Non-Executive & Independent Director6.2yrsNessun datoNessun dato
Sim Seng Lim
Non-Executive & Independent Director1.3yrsNessun datoNessun dato
Wern-Yuen Tan
Non-Executive & Independent Director3.4yrsNessun datoNessun dato
Chuan Neo Chong
Non-Executive & Independent Director3.2yrsNessun datoNessun dato
Jao Yiu Sung
Independent Non-Executive Director3yrsNessun datoNessun dato
Liangjian Lu
Non-Executive & Non-Independent Director1.3yrsNessun datoNessun dato

4.2yrs

Durata media

61yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di BSL sono considerati esperti (durata media dell'incarico 4.2 anni).


Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2024/12/27 19:40
Prezzo dell'azione a fine giornata2024/12/27 00:00
Guadagni2024/06/30
Guadagni annuali2023/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* esempio per i titoli statunitensi, per quelli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più , cliccate qui.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su .

Fonti analitiche

Raffles Medical Group Ltd è coperta da 20 analisti. 8 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
David MakCGS International
Patrick YauCitigroup Inc
Horng Han LowCLSA